1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow CNV: new trials by email Literature Review of CNV trials Research Report on CNV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration Efalizumab, Ranibizumab - Age Related Macular Degeneration, AMD | Phase 1 | Withdrawn | Vitreous -Retina- Macula Consultants of New York | 2008-03-01 | 2015-07-07 | |
| Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration Combretastatin A-4 phosphate, Combretastatin A-4 Phosphate - Combretastatin A4 Phosphate, Age-related Macular Degeneration | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 8 | 2003-05-01 | 2017-12-06 |
Macular Degeneration (2) · Choroidal Neovascularization (1)
Eye Diseases (2) · Retinal Degeneration (2) · Retinal Diseases (2) · Choroid Diseases (1) · Metaplasia (1) · Neovascularization, Pathologic (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Uveal Diseases (1)
Ranibizumab (1) · efalizumab (1) · fosbretabulin (1)
Johns Hopkins University (1) · Vitreous -Retina- Macula Consultants of New York (1)
United States (2)
Jason S Slakter, MD (1) · Quan D Nguyen, MD, MSc (1)